Neuropilin-2: a new molecular target for antiangiogenic and antitumor strategies.
Narazaki
Masashi
M
Segarra
Marta
M
Tosato
Giovanna
G
D020533:Angiogenesis Inhibitors / Q000494:pharmacology*; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D006801:Humans; D051379:Mice; D039943:Neuropilin-2 / Q000187:drug effects* / Q000378:metabolism*; D040262:Receptors, Vascular Endothelial Growth Factor / Q000378:metabolism; D039961:Semaphorins / Q000378:metabolism
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D039943:Neuropilin-2; D039961:Semaphorins; D040262:Receptors, Vascular Endothelial Growth Factor